|
|
1.
|
Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. MedStar authors:
Year: 2018
Citation: - Journal of Clinical Endocrinology & Metabolism. 103(2):365-369, 2018 02 01.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Internal Medcine
Medline publication type:
All authors: - Brownell I, Del Rivero J, Ebenuwa I, Gulley J, Kommalapati A, Strauss J, Tella SH, Zhao C
|
|
|
2.
|
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
Year: 2019
Citation: - Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
|
